Home | All trial_arm_group

[RDF data]
Arm Group #10250

Resource URI: http://static.linkedct.org/resource/arm_group/10250
is linkedct:arm_group of <http://static.linkedct.org/resource/trials/NCT00696735>
linkedct:arm_group_id 10250 (xsd:int)
linkedct:arm_group_label 1
linkedct:arm_group_type Active Comparator
linkedct:description standard chemotherapy arm, the CHVP (cyclophosphamide, low-dose doxorubicin, teniposide, and prednisone) regimen consisted of cyclophosphamide (600 mg/m2), doxorubicin (25 mg/m2), and teniposide (60 mg/m2), all administered intravenously on day 1, and prednisone (40 mg/m2), administered orally on days 1 to 5.4,12 Treatment consisted of a 6-course induction phase administered monthly, followed, for responders and patients presenting a stable disease, by a maintenance phase that consisted of 1 cycle every 2 months for 1 year. Concomitant subcutaneous interferon alfa-2b was administered at 5 x 106 3 times a week for 18 months.
rdfs:label Arm Group #10250
rdf:type linkedct:trial_arm_group